137 related articles for article (PubMed ID: 8284572)
1. Nonrhabdomyosarcoma in children: prognostic factors influencing survival.
Rao BN
Semin Surg Oncol; 1993; 9(6):524-31. PubMed ID: 8284572
[TBL] [Abstract][Full Text] [Related]
2. Pediatric nonrhabdomyosarcomas of the extremities. Influence of size, invasiveness, and grade on outcome.
Rao BN; Santana VM; Parham D; Pratt CB; Fleming ID; Hudson M; Fontanesi J; Philippe P; Schell MJ
Arch Surg; 1991 Dec; 126(12):1490-5. PubMed ID: 1842178
[TBL] [Abstract][Full Text] [Related]
3. Modified staging system for extremity soft tissue sarcomas.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
[TBL] [Abstract][Full Text] [Related]
4. Pediatric soft tissue sarcomas of nonmyogenic origin.
McCoy DM; Levine EA; Ferrer K; Das Gupta TK
J Surg Oncol; 1993 Jul; 53(3):149-53. PubMed ID: 8331936
[TBL] [Abstract][Full Text] [Related]
5. Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites.
Ferrari A; Magni C; Bergamaschi L; Cecchetto G; Alaggio R; Milano GM; Bertolini P; Basso E; Manzitti C; Di Martino M; Giurici N; Melchionda F; Cecinati V; Chiaravalli S; Affinita MC; Scagnellato A; Casanova M; Bisogno G
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233470
[TBL] [Abstract][Full Text] [Related]
6. Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems.
Khoury JD; Coffin CM; Spunt SL; Anderson JR; Meyer WH; Parham DM
Cancer; 2010 May; 116(9):2266-74. PubMed ID: 20166208
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
8. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience.
Nathan PC; Tsokos M; Long L; Bernstein D; Wexler LH; Mackall CL; Helman LJ
Pediatr Blood Cancer; 2005 May; 44(5):449-54. PubMed ID: 15547929
[TBL] [Abstract][Full Text] [Related]
10. Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescents.
Navid F; Billups CA; Krasin MJ; Davidoff AM; Harper J; Rao BN; Spunt SL
J Pediatr Surg; 2009 Oct; 44(10):1965-71. PubMed ID: 19853756
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.
Singer S; Corson JM; Gonin R; Labow B; Eberlein TJ
Ann Surg; 1994 Feb; 219(2):165-73. PubMed ID: 8129487
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma.
Spunt SL; Hill DA; Motosue AM; Billups CA; Cain AM; Rao BN; Pratt CB; Merchant TE; Pappo AS
J Clin Oncol; 2002 Aug; 20(15):3225-35. PubMed ID: 12149295
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in soft-tissue sarcomas: what have we learnt?
Choong PF; Rüdiger HA
Expert Rev Anticancer Ther; 2008 Feb; 8(2):139-46. PubMed ID: 18279053
[No Abstract] [Full Text] [Related]
14. [Treatment results of pediatric soft tissue sarcomas at the 2nd Department of Pediatrics, Semmelweis University].
Bots B; Eipel O; Terkovics L; Felkai L; Csóka M
Magy Onkol; 2018 Dec; 62(4):222-229. PubMed ID: 30540864
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
Asano N; Yoshida A; Ogura K; Kobayashi E; Susa M; Morioka H; Iwata S; Ishii T; Hiruma T; Chuman H; Kawai A
Ann Surg Oncol; 2015 Aug; 22(8):2624-32. PubMed ID: 25663591
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas.
Choi YB; Yi ES; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2016 Jul; 31(7):1055-62. PubMed ID: 27366002
[TBL] [Abstract][Full Text] [Related]
17. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis.
Rööser B; Attewell R; Berg NO; Rydholm A
Acta Orthop Scand; 1987 Oct; 58(5):516-22. PubMed ID: 3425281
[TBL] [Abstract][Full Text] [Related]
18. The management of adult soft tissue sarcomas.
Mendenhall WM; Indelicato DJ; Scarborough MT; Zlotecki RA; Gibbs CP; Mendenhall NP; Mendenhall CM; Enneking WF
Am J Clin Oncol; 2009 Aug; 32(4):436-42. PubMed ID: 19657238
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 51 cases with rare childhood soft tissue sarcomas].
Cai MX; Pan C; Ye QD; Zhou M; Gao YJ; Hu WT; Tang JY
Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):917-922. PubMed ID: 27938592
[No Abstract] [Full Text] [Related]
20. Clinical features and outcomes of young patients with head and neck non-rhabdomyosarcoma soft tissue sarcomas.
Federico SM; Gilpin D; Samant S; Billups CA; Spunt SL
Head Neck; 2015 Jan; 37(1):76-83. PubMed ID: 24327514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
